{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:08:14Z","timestamp":1789672094085,"version":"4.0.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"DOI":"10.1007\/s43441-026-01046-3","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:40:55Z","timestamp":1789670455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of IMPD Deficiencies in the Clinical Trial Approval Process"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8986-3520","authenticated-orcid":false,"given":"Sanja","family":"Arsi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"1046_CR1","first-page":"14","volume-title":"Design and analysis of clinical trials, concepts and methodologies","author":"SC Chow","year":"2004","unstructured":"Chow SC. Liu JP. In: Chow SC, Liu JP, editors. Design and analysis of clinical trials, concepts and methodologies. 2nd ed. New Jersey: Wiley; 2004. p. 14\u20135.","edition":"2"},{"key":"1046_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0149-6395(01)80017-9","volume-title":"Handbook of modern pharmaceutical analysis","author":"H Chokshi","year":"2001","unstructured":"Chokshi H. Schostack K. In: Ahuja S, Scypinski S, editors. Handbook of modern pharmaceutical analysis, vol. III. San Diego: Academic Press; 2001. p. 499\u2013525."},{"key":"1046_CR3","unstructured":"Dragojevic Simic V, Dobri\u0107 S, Mikov Momir, Ranko Skrbic et al. Fundamentals of Clinical Pharmacology, 1st ed. Belgrade, Serbia: Media Center \"Odbrana\". 2011: pp. 107\u2013180."},{"key":"1046_CR4","unstructured":"Directive 2001\/20\/EC of the European parliament and of the council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. EUR Lex, [cited 2024 July 28]. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32001L0020&qid=1722145143672."},{"key":"1046_CR5","unstructured":"Detailed guidance on the request to the competent authorities for authorisation of a clinical trial on a medicinal product for human use, the notification of substantial amendments and the declaration of the end of the trial (CT-1) (2010\/C 82\/01). EUR Lex, [cited 2024 July 28]. https:\/\/eur-lex.europa.eu\/legal-ontent\/EN\/TXT\/?uri=CELEX:52010XC0330(01)."},{"key":"1046_CR6","unstructured":"Regulation (EU) no 536\/2014 of the European parliament and of the council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001\/20\/EC. EUR Lex, [cited 2024 July 28]. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32014R0536&qid=1722146664853."},{"key":"1046_CR7","unstructured":"EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use Annex 13 Investigational Medicinal Products. Health EC, [cited 2024 July 28]. https:\/\/health.ec.europa.eu\/document\/download\/eb43a2ab-4691-4cab-938e-874f2307dca3_en?filename=2009_06_annex13.pdf."},{"key":"1046_CR8","unstructured":"Guideline on the requirements to the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials, 31.03.2006. Health EC, [cited 2024 July 28]. https:\/\/health.ec.europa.eu\/document\/download\/deaa5848-d457-4c17-8674-71bad35df642_en?filename=18540104en_en.pdf."},{"key":"1046_CR9","unstructured":"Guideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials, September 2018. Health EC, [cited 2024 July 28] https:\/\/health.ec.europa.eu\/document\/download\/9b0daca5-4dd4-4aed-8e39-c2bf7138db4f_en?filename=biological_investigational_medicinal_en.pdf."},{"key":"1046_CR10","unstructured":"Guideline on the requirements to the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials, 27.01.2022. Health EC, [cited 2024 July 28]. https:\/\/health.ec.europa.eu\/document\/download\/257ad13a-c480-4c34-82df-1760ad1d5f68_en?filename=mp_eudralex_guideline-chemical_en_1.pdf."},{"key":"1046_CR11","unstructured":"Guideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials, 27.01.2022. Health EC, [cited 2024 July 28]. https:\/\/health.ec.europa.eu\/document\/download\/bd71e2e7-4df1-491a-8775-c6483a97f749_en?filename=mp_eudralex_guideline-quality_en_0.pdf."},{"key":"1046_CR12","unstructured":"Title 21--food and drugs chapter i--food and drug administration department of health and human services subchapter d - drugs for human use, part 312, investigational new drug application, FDA. [cited 2024 July 28]. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRsearch.cfm?CFRPart=312."},{"key":"1046_CR13","unstructured":"Organisation of the common technical document for the registration of pharmaceuticals for human use M4, 15.06.2016, ICH. [cited 2024 July 28]. https:\/\/database.ich.org\/sites\/default\/files\/M4_R4__Guideline.pdf."},{"key":"1046_CR14","unstructured":"Template for the qualified person's declaration equivalence to EU GMP for investigational medicinal products manufactured in third countries, Health EC. [cited 2024 July 28]. https:\/\/health.ec.europa.eu\/document\/download\/230da759-7f10-447e-ba1a-cf8e31666cc9_en?filename=2013-12_qp_template_imp.pdf."}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01046-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:41:00Z","timestamp":1789670460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-026-01046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":14,"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01046-3","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}